Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-17-341887
Filing Date
2017-11-14
Accepted
2017-11-14 09:02:08
Documents
5
Period of Report
2017-11-14

Document Format Files

Seq Description Document Type Size
1 6-K d462703d6k.htm 6-K 12464
2 EX-99.1 d462703dex991.htm EX-99.1 178236
3 EX-99.2 d462703dex992.htm EX-99.2 78777
4 EX-99.3 d462703dex993.htm EX-99.3 65576
5 GRAPHIC g462703g68l40.jpg GRAPHIC 4863
  Complete submission text file 0001193125-17-341887.txt   342863
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38079 | Film No.: 171198624
SIC: 2834 Pharmaceutical Preparations